En trámite
Until recently measuring the “signs” of brain disease same way as you might measure heart rate or blood pressure to understand heart disease has been very difficult. Diagnosis has therefore been based assessment of the “symptoms”. PRISM aims to use new techniques to start a new signs, as opposed symptoms, based approach for the diagnosis of brain disorders.
En trámite
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115916. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.